Literature DB >> 17587885

The transdifferentiation of bone-marrow-derived cells in colonic mucosal regeneration after dextran-sulfate-sodium-induced colitis in mice.

Yujiro Hayashi1, Shingo Tsuji, Masahiko Tsujii, Tsutomu Nishida, Shuji Ishii, Tohru Nakamura, Hiroshi Eguchi, Sunao Kawano.   

Abstract

Bone-marrow-derived cells (BMDCs) transdifferentiate into various types of gastrointestinal cells. The precise transdifferentiation of BMDCs in gut regeneration, however, is controversial. In this study, we examined the transdifferentiation of BMDCs in the regeneration of damaged colonic epithelia. Lethally irradiated wild-type female mice (C57BL/6) were rescued by bone marrow transplantation from male green fluorescent protein transgenic mouse donors. Chronic colitis was induced by administering 3% dextran sulfate sodium (DSS) in the drinking water for 5 days on day 28 after the bone marrow transplantation. The mice were killed on day 25 after DSS administration. BMDC phenotypes were examined by confocal microscopy and fluorescence immunohistochemistry. BMDCs were frequently observed in the vimentin-positive colonic interstitial cells, which also expressed alpha-smooth muscle actin and had a spindle-like morphology, but did not express leukocyte common antigen. Green-fluorescent-protein-positive cells were rarely or less frequently found in Ki-67-positive proliferating cells, cytokeratin-positive epithelial cells, or CD31-positive endothelial cells. BMDCs frequently transdifferentiated into subepithelial myofibroblasts and fibroblasts, and often continued to reside in the colonic subepithelia after the experimental colitis had healed. In conclusion, our data indicate the fate of BMDCs, which might be involved in the healing process of the colon after DSS-induced colitis. Our data show that BMDCs contribute to colonic interstitial cells after the colitis has healed. Understanding the fate of BMDCs may be important for stem cell therapy by BMDCs. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587885     DOI: 10.1159/000104148

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  13 in total

1.  Stem cells, phenotypic inversion, and differentiation.

Authors:  Robert W Siggins; Ping Zhang; David Welsh; Nicole J Lecapitaine; Steve Nelson
Journal:  Int J Clin Exp Med       Date:  2008-01-20

2.  Adult bone marrow cells can differentiate into hemopoietic cells and endothelial cells but not into other lineage cells in normal growth and normal life.

Authors:  Seiji Yanai; Yasushi Adachi; Ming Shi; Akio Shigematsu; Chieko Shima; Yuichiro Imai; A-Hon Kwon; Susumu Ikehara
Journal:  Int J Hematol       Date:  2010-01-20       Impact factor: 2.490

3.  Human Barrett's adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant.

Authors:  Lloyd Hutchinson; Bjorn Stenstrom; Duan Chen; Bilal Piperdi; Sara Levey; Stephen Lyle; Timothy C Wang; JeanMarie Houghton
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

4.  EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool.

Authors:  Evan Colletti; Deena El Shabrawy; Melisa Soland; Takashi Yamagami; Saloomeh Mokhtari; Craig Osborne; Karen Schlauch; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  FASEB J       Date:  2013-02-14       Impact factor: 5.191

5.  Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat.

Authors:  Hiroki Tanaka; Yoshiaki Arimura; Takashi Yabana; Akira Goto; Masayo Hosokawa; Kanna Nagaishi; Kentaro Yamashita; Hiroyuki Yamamoto; Yasushi Sasaki; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2010-09-17       Impact factor: 7.527

Review 6.  Intestinal stem cells and celiac disease.

Authors:  Anna Chiara Piscaglia
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

7.  Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors.

Authors:  Shuhei Watanabe; Yoshiaki Arimura; Kanna Nagaishi; Hiroyuki Isshiki; Kei Onodera; Masanao Nasuno; Kentaro Yamashita; Masashi Idogawa; Yasuyoshi Naishiro; Masaki Murata; Yasushi Adachi; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-11-12       Impact factor: 7.527

Review 8.  Stem cells as a potential future treatment of pediatric intestinal disorders.

Authors:  Troy A Markel; Paul R Crisostomo; Tim Lahm; Nathan M Novotny; Frederick J Rescorla; Joseph Tector; Daniel R Meldrum
Journal:  J Pediatr Surg       Date:  2008-11       Impact factor: 2.545

9.  TGF-beta signaling-dependent alleviation of dextran sulfate sodium-induced colitis by mesenchymal stem cell transplantation.

Authors:  Chong Wang; Jing Chen; Ling Sun; Yanfang Liu
Journal:  Mol Biol Rep       Date:  2014-04-16       Impact factor: 2.316

10.  Comparison of the population capacity of hematopoietic and mesenchymal stem cells in experimental colitis rat model.

Authors:  Yaming Wei; Yuqiang Nie; Jieying Lai; Yu-Jui Yvonne Wan; Yuyuan Li
Journal:  Transplantation       Date:  2009-07-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.